ABSTRACT
The leaves of Acanthus montanus and Alstonia congensis were powdered, screened for phytochemicals and their antibacterial activities. Antibacterial activities of the crude extracts against ATCC strains of Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 25923), Enterococcus faecalis (ATCC 7080), and Salmonella typhi (ATCC 7080) were investigated using agar diffusion and broth dilution methods. Gentamicin, a standard antibiotic was used as control. The mean diameter zone of inhibition produced by ethanol extract of Alstonia congensis and Acanthus montanus on the test organisms at various concentrations were as follows: S. aureus (15mm at 100mg/ml, 10mm at 50mg/ml and 9mm at 25mg/ml for A. montanus; 13mm at 100mg/ml, 11.5mm at 50mg/ml and 8mm at 25mg/ml for A. congensis). E. coli (12.5mm at 100mg/ml, 11mm at 50mg/ml and 9.5mm at 25mg/ml for A. montanus with no effect by extract of A.congensis). E. faecalis (11mm at 100mg/ml and 10mm at 50mg/ml for A. montanus; 10mm at 100mg/ml and 9mm at 50mg/ml for A. congensis). The extracts at various concentrations had no effect on Salmonella typhi. The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) values of the ethanol extract of Acanthus montanus were as follows; 12.5mg/ml and 25mg/ml for S. aureus, 25mg/ml and 50mg/ml for E. coli and 25mg/ml and 50mg/ml for Enterococcus faecalis. The MIC and MBC values of the ethanol extract of Alstonia congensis were as follows; 6.25mg/ml and 12.5mg/ml for S. aureus, 25mg/ml and 50mg/ml for Enterococcus faecalis. The phytochemical screening of the plants Acanthus montanus and Alstonia congensis was also carried out and it was found that the plants contained flavonoids, saponins, tannin and terpenoids. In conclusion, the crude extracts of Alstonia congensis and Acanthus montanus possess strong antibacterial activities and further investigation should be carried out to isolate pure compounds and determine the mechanisms of action of the plants.
TABLE OF CONTENTS
Title
page i
Certification
page ii
Dedication iii
Acknowledgements iv
Table
of contents v
List
of tables vii
List
of figures viii
Abstract ix
CHAPTER
ONE
1.0 INTRODUCTION 1
1.1
Aims and Objectives 3
CHAPTER
TWO
2.0 LITERATURE REVIEW 4
2.1 Importance of medicinal plant in
Traditional Medical practice 4
2.2 The plant Alstonia congensis 5
2.3 Documented Species Distribution 6
2.4 Systematic Position of A. congensis 7
2.5 Chemical Composition (Phytochemistry) of A. congensis 7
2.6 Ethnobotanical Uses of A. congensis 10
2.7 Antibacterial properties of A. congensis 11
2.8 The
Plant Acanthus montanus 13
2.9 Origin
and geographical distribution of A. montanus 14
2.10 Scientific
classification of A. montanus 14
2.10.1 Common
names for Acanthus montanus 14
2.10.2 Vernacular names for Acanthus
montanus 15
2.10.3 Propagation and management of Acanthus
montanus 15
2.10.4 Ethnomedical Uses of Acanthus
montanus 16
2.10.5 Biological Activities of the Plant Acanthus
montanus 17
2.10.6 Antimicrobial, anti-inflammatory and
immunological activity 19
2.10.7 Anti-abortifacient activity 20 CHAPTER THREE
3.0 MATERIALS AND METHODS 22
3.1 Plant
samples 22
3.2 Preparation of samples for analysis 22
3.3 Preparation of Stock Solution of Plant
Extract 22
3.4 Reactivation of Test Microorganism 22
3.5 Antimicrobial Testing 23
3.6 Determination of MIC of Plant Extracts 24
CHAPTER FOUR
4.0 RESULTS 25
CHAPTER FIVE
5.0 DISCUSSION, CONCLUSION AND RECOMMENDATION 29
5.1 Discussion 29
5.2 Conclusion 30
5.3 Recommendation 30
REFERENCES 31
LIST OF TABLES
Table
|
Titles
|
Page
|
1
|
Forkloric uses of A. congensis
|
11
|
2
|
Mean diameter
zone of inhibition (mm) produced by ethanol extract of Acanthus montanus and
Alstonia congensis on the test organisms
|
26
|
3
4
|
Minimum
inhibitory concentration and Minimum bactericidal values of
Acanthus montanus and Alstonia congensis, against susceptible organisms
Qualitative
analysis of the phytochemical screening of test plants
| |
LIST OF FIGURES
Figure
Titles
Page
1 Alstonia congensis plant 7
2 Acanthus
montanus plant in the wild 13
CHAPTER ONE
INTRODUCTION
Plants
have traditionally provided a source of hope for novel drug compounds, as plant
herbal mixtures have made large contributions to human health and well-being
(Iwu et al., 1999).
In
developing countries, bacterial infections are widespread, especially in
informal settlements, due to poor sanitation and unhygienic conditions
(Rasoanairo and Ratsimamanga-Urverg, 1993). Most of the pathogens causing
enteric infections have developed resistance to the commonly prescribed
antibiotics which increase the likelihood of being hospitalized and increase
the length of stay in the hospital (Johanna
et al., 2005) and
increased use of a particular antibiotic could lead to increased bacterial
resistance.
Medicinal
plants have been found as important contributors to the pharmaceutical,
agriculture and food industries. With the onset of the synthetic era,
pharmaceutical industries are producing a lot of synthetic drugs that help to
alleviate chronic diseases. With the passage of time many problems associated
with frequent use of synthetic drugs become prominent like severe side effects
and resistance of microbes against these drugs. On the other side synthetic
drugs are expensive and a large population cannot afford these drugs. Hence
research on medicinal plants has been intensified all over the world to remedy
these situations.
Plants have been used for thousands of years to flavor and
conserve food, to treat health disorders and to prevent diseases including
epidemics. The knowledge of their healing properties has been transmitted over
the centuries within and among human communities. Products derived from plants
may potentially control microbial growth in diverse situations and in the
specific case of disease treatment (Kong et al., 2003).
The
use and search for drugs derived from plants have accelerated in recent years.
A truncated history of the contribution of plants to medicine was given by
Philipson, (2001) with 25 to 50 per cent of current pharmaceuticals in use
derived from plants. Traditional healers have long been using plants to prevent
or cure infectious diseases; western medicine also is moving in this direction.
Plants are storehouses of a wide variety of secondary metabolites, such as
tannins, terpenoids, alkaloids and flavonoids which have demonstrated their
antimicrobial properties in vitro (Karim et al., 2011).
Infectious diseases represent an important cause of morbidity and
mortality among the general population, particularly in developing countries.
Plants used for traditional medicine contain a wide range of substances that
can be used to treat chronic as well as infectious diseases. Today most parts
of developing nations find itself in the midst of a multiplicity of problems
particularly including antibiotic resistance in the area of health care. The
situation in this sector is alarming because of the emergence of new diseases.
Consequently, the necessity of evolving new herbal remedies is on the
ascendancy. In the present scenario where 80 per cent of the world population
has no access to the benefits of western medicines due to financial
constraints, it is quite necessary to emphasize the relevance of traditional
remedies which constitute a major part of the health care system in the developing
countries and are also entering the therapeutics in the developed countries.
Most plants contain several compounds with antimicrobial
properties for protection against aggressor agents, especially microorganisms.
Active compounds found in some plants have antiseptic action; for example,
thyme has thymol and carvacrol, clove has eugenol and isoeugenol, and oregano
has carvacrol and terpinenol-4. In some cases, terpenes from essences that are
soluble in water have higher antibacterial power than others (Erdogrul,
2002). The action mechanisms of natural compounds are
related to disintegration of cytoplasmic membrane, destabilization of the
proton motive force (PMF), electron flow, active transport and coagulation of
the cell content.
Resistance
to antimicrobial agents is emerging in a wide variety of pathogens and multiple
drug resistance is becoming common in diverse organisms such as Staphylococcus
sp and Salmonella sp. (Ahmed and Beg, 2001).
The
appearance of resistant organisms paved the way to the occurrence of infections
that are only treated by a limited number of antimicrobial agents the gradual
rise in resistance of bacterial and fungal pathogens for antibiotics and
antifungal highlights the need to find alternative sources from medicinal plants.
1.2
Aims
and Objectives
1.
To determine the antimicrobial activity of the ethanol extract of the leaves of
plants Acanthus montanus and Alstonia congensis against some
bacterial pathogens
2.
To screen the medicinal plants for phytochemicals
3.
To determine the Minimum inhibitory concentration and minimum bactericidal
concentration of the extracts.
Buyers has the right to create
dispute within seven (7) days of purchase for 100% refund request when
you experience issue with the file received.
Dispute can only be created when
you receive a corrupt file, a wrong file or irregularities in the table of
contents and content of the file you received.
ProjectShelve.com shall either
provide the appropriate file within 48hrs or
send refund excluding your bank transaction charges. Term and
Conditions are applied.
Buyers are expected to confirm
that the material you are paying for is available on our website
ProjectShelve.com and you have selected the right material, you have also gone
through the preliminary pages and it interests you before payment. DO NOT MAKE
BANK PAYMENT IF YOUR TOPIC IS NOT ON THE WEBSITE.
In case of payment for a
material not available on ProjectShelve.com, the management of
ProjectShelve.com has the right to keep your money until you send a topic that
is available on our website within 48 hours.
You cannot change topic after
receiving material of the topic you ordered and paid for.
Login To Comment